BRPI0618638A2 - mineral nutrient salts stabilized with amino acids and / or ammonium salt, product for the treatment of deficiency deficiencies, food supplement, product to be used as fertilizer or foliar fertilizer, and process for the synthesis of mineral salts, and copper or iron or manganese - Google Patents
mineral nutrient salts stabilized with amino acids and / or ammonium salt, product for the treatment of deficiency deficiencies, food supplement, product to be used as fertilizer or foliar fertilizer, and process for the synthesis of mineral salts, and copper or iron or manganese Download PDFInfo
- Publication number
- BRPI0618638A2 BRPI0618638A2 BRPI0618638-6A BRPI0618638A BRPI0618638A2 BR PI0618638 A2 BRPI0618638 A2 BR PI0618638A2 BR PI0618638 A BRPI0618638 A BR PI0618638A BR PI0618638 A2 BRPI0618638 A2 BR PI0618638A2
- Authority
- BR
- Brazil
- Prior art keywords
- salts
- product
- ammonium salt
- amino acid
- manganese
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 54
- 150000003839 salts Chemical class 0.000 title claims abstract description 48
- 239000000047 product Substances 0.000 title claims abstract description 43
- 150000003863 ammonium salts Chemical class 0.000 title claims abstract description 40
- 235000010755 mineral Nutrition 0.000 title claims abstract description 34
- 239000011707 mineral Substances 0.000 title claims abstract description 34
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title claims abstract description 27
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 13
- 238000000034 method Methods 0.000 title claims abstract description 13
- 230000008569 process Effects 0.000 title claims abstract description 13
- 229910052742 iron Inorganic materials 0.000 title claims abstract description 12
- 239000003337 fertilizer Substances 0.000 title claims abstract description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims description 17
- 230000015572 biosynthetic process Effects 0.000 title claims description 10
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 title claims description 8
- 229910052802 copper Inorganic materials 0.000 title claims description 8
- 239000010949 copper Substances 0.000 title claims description 8
- 230000007812 deficiency Effects 0.000 title claims description 7
- 238000003786 synthesis reaction Methods 0.000 title claims description 6
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 title claims description 4
- 229910052748 manganese Inorganic materials 0.000 title claims description 4
- 239000011572 manganese Substances 0.000 title claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 38
- 229910052751 metal Inorganic materials 0.000 claims abstract description 15
- 239000002184 metal Substances 0.000 claims abstract description 15
- 150000001768 cations Chemical class 0.000 claims abstract description 6
- 150000001449 anionic compounds Chemical class 0.000 claims abstract description 3
- 229910001412 inorganic anion Inorganic materials 0.000 claims abstract description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 38
- 239000000243 solution Substances 0.000 claims description 28
- 229960002449 glycine Drugs 0.000 claims description 19
- 239000007864 aqueous solution Substances 0.000 claims description 15
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 claims description 14
- 239000011575 calcium Substances 0.000 claims description 14
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 13
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 12
- 229910052791 calcium Inorganic materials 0.000 claims description 12
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 9
- 239000011701 zinc Substances 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 8
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 8
- 238000010521 absorption reaction Methods 0.000 claims description 8
- 230000008020 evaporation Effects 0.000 claims description 8
- 238000001704 evaporation Methods 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 7
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 6
- 239000001530 fumaric acid Substances 0.000 claims description 6
- 235000016709 nutrition Nutrition 0.000 claims description 6
- 230000035764 nutrition Effects 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 150000001450 anions Chemical class 0.000 claims description 5
- 239000010941 cobalt Substances 0.000 claims description 5
- 229910017052 cobalt Inorganic materials 0.000 claims description 5
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 5
- 230000036541 health Effects 0.000 claims description 5
- 239000011777 magnesium Substances 0.000 claims description 5
- 229910052749 magnesium Inorganic materials 0.000 claims description 5
- 150000002696 manganese Chemical class 0.000 claims description 5
- 235000007079 manganese sulphate Nutrition 0.000 claims description 5
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 5
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 5
- 239000011591 potassium Substances 0.000 claims description 5
- 229910052700 potassium Inorganic materials 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 229910052725 zinc Inorganic materials 0.000 claims description 5
- 241000282412 Homo Species 0.000 claims description 4
- 239000004472 Lysine Substances 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 4
- 159000000007 calcium salts Chemical class 0.000 claims description 4
- 235000011850 desserts Nutrition 0.000 claims description 4
- 235000013905 glycine and its sodium salt Nutrition 0.000 claims description 4
- 229910052759 nickel Inorganic materials 0.000 claims description 4
- 229910021653 sulphate ion Inorganic materials 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000003643 water by type Substances 0.000 claims description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- 241000196324 Embryophyta Species 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 239000001175 calcium sulphate Substances 0.000 claims description 3
- 235000011132 calcium sulphate Nutrition 0.000 claims description 3
- 235000013339 cereals Nutrition 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 235000011167 hydrochloric acid Nutrition 0.000 claims description 3
- 238000010348 incorporation Methods 0.000 claims description 3
- 239000001630 malic acid Substances 0.000 claims description 3
- 235000011090 malic acid Nutrition 0.000 claims description 3
- 239000011702 manganese sulphate Substances 0.000 claims description 3
- 239000011785 micronutrient Substances 0.000 claims description 3
- 235000013369 micronutrients Nutrition 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 239000001103 potassium chloride Substances 0.000 claims description 3
- 235000011164 potassium chloride Nutrition 0.000 claims description 3
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 claims description 3
- 229910052939 potassium sulfate Inorganic materials 0.000 claims description 3
- 235000011151 potassium sulphates Nutrition 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 3
- 235000011152 sodium sulphate Nutrition 0.000 claims description 3
- 230000003381 solubilizing effect Effects 0.000 claims description 3
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 2
- 235000007319 Avena orientalis Nutrition 0.000 claims description 2
- 244000075850 Avena orientalis Species 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims description 2
- 235000008429 bread Nutrition 0.000 claims description 2
- 235000014121 butter Nutrition 0.000 claims description 2
- 235000012182 cereal bars Nutrition 0.000 claims description 2
- 235000013351 cheese Nutrition 0.000 claims description 2
- 239000008298 dragée Substances 0.000 claims description 2
- 239000007911 effervescent powder Substances 0.000 claims description 2
- 235000013312 flour Nutrition 0.000 claims description 2
- 235000015203 fruit juice Nutrition 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 235000015110 jellies Nutrition 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000007937 lozenge Substances 0.000 claims description 2
- 235000013310 margarine Nutrition 0.000 claims description 2
- 235000015927 pasta Nutrition 0.000 claims description 2
- 239000001120 potassium sulphate Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 235000014347 soups Nutrition 0.000 claims description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 235000013618 yogurt Nutrition 0.000 claims description 2
- 239000011686 zinc sulphate Substances 0.000 claims description 2
- 235000009529 zinc sulphate Nutrition 0.000 claims description 2
- YPFNIPKMNMDDDB-UHFFFAOYSA-K 2-[2-[bis(carboxylatomethyl)amino]ethyl-(2-hydroxyethyl)amino]acetate;iron(3+) Chemical compound [Fe+3].OCCN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O YPFNIPKMNMDDDB-UHFFFAOYSA-K 0.000 claims 1
- 239000008365 aqueous carrier Substances 0.000 claims 1
- 235000010633 broth Nutrition 0.000 claims 1
- 235000012495 crackers Nutrition 0.000 claims 1
- 150000002500 ions Chemical class 0.000 claims 1
- 239000003264 margarine Substances 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
- 235000005985 organic acids Nutrition 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 9
- -1 organic acid anions Chemical class 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 235000019640 taste Nutrition 0.000 abstract description 3
- 241000711981 Sais Species 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 description 39
- 239000004471 Glycine Substances 0.000 description 15
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 description 7
- 239000011773 ferrous fumarate Substances 0.000 description 7
- 235000002332 ferrous fumarate Nutrition 0.000 description 7
- 229960000225 ferrous fumarate Drugs 0.000 description 7
- RWYRUDPAALLKPX-UHFFFAOYSA-N 2,2-difluoro-n-methylethanamine;hydrochloride Chemical compound Cl.CNCC(F)F RWYRUDPAALLKPX-UHFFFAOYSA-N 0.000 description 6
- 239000001749 Calcium fumarate Substances 0.000 description 6
- 235000019296 calcium fumarate Nutrition 0.000 description 6
- GICLSALZHXCILJ-UHFFFAOYSA-N ctk5a5089 Chemical compound NCC(O)=O.NCC(O)=O GICLSALZHXCILJ-UHFFFAOYSA-N 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 150000002739 metals Chemical class 0.000 description 5
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 4
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 3
- 239000000920 calcium hydroxide Substances 0.000 description 3
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- HJSYJHHRQVHHMQ-TYYBGVCCSA-L zinc;(e)-but-2-enedioate Chemical compound [Zn+2].[O-]C(=O)\C=C\C([O-])=O HJSYJHHRQVHHMQ-TYYBGVCCSA-L 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 235000021321 essential mineral Nutrition 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000014106 fortified food Nutrition 0.000 description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000018977 lysine Nutrition 0.000 description 2
- 229910001437 manganese ion Inorganic materials 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000025371 Taste disease Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000004791 biological behavior Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000027721 electron transport chain Effects 0.000 description 1
- 230000010235 enterohepatic circulation Effects 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000020509 fortified beverage Nutrition 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910001608 iron mineral Inorganic materials 0.000 description 1
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 235000019656 metallic taste Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 150000002891 organic anions Chemical class 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229940093914 potassium sulfate Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229960003010 sodium sulfate Drugs 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
- A23D7/0056—Spread compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/10—Shaping or working-up of animal feeding-stuffs by agglomeration; by granulation, e.g. making powders
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/25—Shaping or working-up of animal feeding-stuffs by extrusion
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- C—CHEMISTRY; METALLURGY
- C05—FERTILISERS; MANUFACTURE THEREOF
- C05D—INORGANIC FERTILISERS NOT COVERED BY SUBCLASSES C05B, C05C; FERTILISERS PRODUCING CARBON DIOXIDE
- C05D9/00—Other inorganic fertilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/02—Iron compounds
- C07F15/025—Iron compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic System
- C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic System without C-Metal linkages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
SAIS DE NUTRIENTES MINERAIS ESTABILIZADOS COM AMINOáCIDOS E/OU SAL DE AMÈNIO, PRODUTO PARA O TRATAMENTO DE DEFICIêNCIAS CARENCIAIS, SUPLEMENTO ALIMENTìCIO, PRODUTO PARA SER USADO COMO FERTILIZANTE OU ADUBO FOLIAR, E, PROCESSO PARA A SINTESE DE SAIS MINERAIS, E SAIS DE COBRE OU FERRO OU MANGANêS. Sais de nutrientes minerais estabilizados com aminoácidos e/ou sal de amónio, produto e suplemento alimentício que compreendem os mesmos, e processos de obtenção, em que os sais são obtidos com ânions de ácidos orgânicos ou ânions inorgânicos e cátions metálicos associados com os aminoácidos e/ou sal de amónio, a invenção apresentando a estrutura geral: { [Ac]^ n+^. Me^ n+^ <sym>n [aminoácido e/ou sal de amónio]} x H~ 2~O, em que<sym> representa uma ligação covalente dativa. Estes novos compostos apresentam melhor sabor e maior solubilidade em água, tomando os mesmos mais biodisponíveis.SALTS OF MINERAL NUTRIENTS STABILIZED WITH AMINO ACIDS AND / OR AMMON SALT, PRODUCT FOR TREATMENT OF DISEASES, FOOD SUPPLEMENT, PRODUCT TO BE USED AS Fertilizer Or Fertilizer, AND, PROCESS FOR SAIS OR SINES DE SAISES IRON OR MANGANES. Salts of mineral nutrients stabilized with amino acids and / or ammonium salt, product and food supplement comprising them, and processes for obtaining them, wherein the salts are obtained with organic acid anions or inorganic anions and metal cations associated with the amino acids and / or ammonium salt, the invention having the general structure: {[Ac] ^ n + ^. Me ^ n + ^ <sym> n [amino acid and / or ammonium salt]} xH 2 O, where <sym> represents a dative covalent bond. These new compounds have better taste and greater water solubility, making them more bioavailable.
Description
"SAIS DE NUTRIENTES MINERAIS ESTABILIZADOS COM AMINOÁCIDOS E/OU SAL DE AMÔNIO, PRODUTO PARA O TRATAMENTO DE DEFICIÊNCIAS CARENCIAIS, SUPLEMENTO ALIMENTÍCIO, PRODUTO PARA SER USADO COMO FERTILIZANTE OU ADUBO FOLIAR, E, PROCESSO PARA A SÍNTESE DE SAIS MINERAIS, E DE SAIS DE COBRE OU FERRO OU MANGANÊS""SALES OF MINERAL NUTRIENTS STABILIZED WITH AMINO ACIDS AND / OR AMMONIUM SALT, PRODUCT FOR TREATMENT OF DISEASES, FOOD SUPPLEMENT, PRODUCT TO BE USED AS FERTILIZER OR FOLIER FERTILIZER, AND, PROCESS FOR SENSIUM AND SATEX COPPER OR IRON OR MANGANESE "
Campo da InvençãoField of the Invention
A presente invenção refere-se ao campo da química e, mais especificamente, da química aplicada à indústria alimentícia e de suplementos dietéticos. A invenção provê novos compostos que são sais minerais estabilizados por aminoácidos e/ou sais de amônio, com uma maior solubilidade em água, com melhoradas características organolépticas e com uma superior biodisponibilidade.The present invention relates to the field of chemistry and, more specifically, chemistry applied to the food industry and dietary supplements. The invention provides novel compounds which are amino acid stabilized salts and / or ammonium salts, with greater water solubility, improved organoleptic characteristics and higher bioavailability.
Descrição da Técnica AnteriorDescription of the Prior Art
A importância de uma dieta adequada que consegue suplementar as necessidades de minerais essenciais tanto para os animais como para os humanos está bem documentada na literatura. Existem numerosos trabalhos que demonstram os problemas acarretados pela deficiência de minerais essenciais e como são revertidos pela ingestão dos mesmos. Os minerais são indispensáveis para os processos metabólicos celulares, ou seja como cofatores de enzimas, formando parte das cadeias de transporte de elétrons, e outros.The importance of a proper diet that can supplement the essential mineral needs for both animals and humans is well documented in the literature. There are numerous works that demonstrate the problems caused by deficiency of essential minerals and how they are reversed by their ingestion. Minerals are indispensable for cellular metabolic processes, ie as cofactors of enzymes, forming part of the electron transport chains, and others.
Eles constituem um grupo de nutrientes (aproximadamente 30) que não administra energia ao organismo, mas apresenta importantes funções reguladoras além de sua função estrutural ao formar parte de muitos tecidos. Eles são constituintes dos ossos e dentes, controlam a composição dos líquidos extra- e intracelulares, e formam parte das enzimas e hormônios, moléculas essenciais para a vida. Dentre os mesmos, podem-se distinguir grandes grupos: macroelementos, denominados assim porque têm que ser supridos em maior quantidade pela dieta ou porque estão em maior proporção nos tecidos corporais: cálcio, fósforo, magnésio, enxofre, potássio, sódio e cloro. Outros, como cobalto, cobre, ferro, cromo, flúor, iodo, manganês, selênio e zinco, são também necessários, porém em quantidades menores, porque são denominados microelementos, ou elementos de traço.They are a group of nutrients (approximately 30) that do not deliver energy to the body but have important regulatory functions beyond their structural function as they form part of many tissues. They are constituents of bones and teeth, control the composition of extra- and intracellular fluids, and form part of the enzymes and hormones, molecules essential for life. Among these, large groups can be distinguished: macroelements, so named because they have to be supplied more in the diet or because they are in greater proportion in body tissues: calcium, phosphorus, magnesium, sulfur, potassium, sodium and chlorine. Others, such as cobalt, copper, iron, chromium, fluorine, iodine, manganese, selenium and zinc, are also needed, but in smaller amounts, because they are called trace elements.
Do mesmo modo, é importante prover níveis apropriados de aminoácidos. Os aminoácidos são a base das proteínas. Os alimentos que consumimos fornecem proteínas. Porém, tais proteínas são não absorvidas normalmente em tal constituição a não ser que, quando de seu desdobramento ("hidrólise" ou ruptura), causado pelo processo de digestão, atravessam a parede intestinal em forma de aminoácidos e de cadeias curtas de peptídeos, conforme o que se denomina circulação entero-hepática. Estas substâncias são incorporadas inicialmente na corrente sangüínea e, desde então, são distribuídas até os tecidos que as necessitam para formar as proteínas, consumidas durante o ciclo vital. Sabe-se que dos 20 aminoácidos protéicos conhecidos, 8 resultam indispensáveis (ou essenciais) para a vida humana, e 2 resultam "semi-indispensáveis". São estes 10 aminoácidos que precisam ser incorporados no organismo na alimentação diária e, ainda mais, nos momentos em que o organismo mais necessita dos mesmos: na disfunção ou na doença. Os aminoácidos essenciais mais problemáticos são o triptofano, a lisina e a metionina. Sua carência é típica em populações em que os cereais e os tubérculos constituem a base da alimentação. O déficit de aminoácidos essenciais afeta muito mais as crianças do que os adultos. Deve-se destacar que, com a falta de apenas um único dos mesmos (aminoácidos essenciais), não será possível sintetizar nenhuma das proteínas em que seja requerido o referido aminoácido. Isto pode dar lugar a diferentes tipos de desnutrição, considerando qual é o aminoácido limitante. É importante destacar que, para uma nutrição correta, uma dieta deve apresentar os níveis adequados de metais essenciais, muitas das formas em que se encontram os referidos metais na natureza não podem ser utilizadas, dado que a maior parte dos compostos que contém os metais não o apresentam de forma tal que possam ser absorvidos, distribuídos e utilizados de modo eficiente.Similarly, it is important to provide appropriate levels of amino acids. Amino acids are the basis of proteins. The foods we eat provide protein. However, such proteins are not normally absorbed in such a constitution unless, upon their unfolding ("hydrolysis" or disruption), caused by the digestion process, they pass through the intestinal wall in the form of amino acids and short peptide chains, as shown. which is called enterohepatic circulation. These substances are initially incorporated into the bloodstream and have since been distributed to the tissues that need them to form the proteins consumed during the life cycle. Of the 20 known protein amino acids, 8 are known to be indispensable (or essential) to human life, and 2 are "semi-indispensable". It is these 10 amino acids that need to be incorporated into the body in the daily diet and even more when the body needs them most: dysfunction or disease. The most problematic essential amino acids are tryptophan, lysine and methionine. Their deficiency is typical in populations where cereals and tubers are the staple diet. The deficit of essential amino acids affects children much more than adults. It should be noted that, with only one of them missing (essential amino acids), it will not be possible to synthesize any of the proteins in which said amino acid is required. This can give rise to different types of malnutrition, considering which is the limiting amino acid. Importantly, for proper nutrition, a diet must have adequate levels of essential metals, many of the ways in which these metals are found in nature cannot be used, as most compounds containing the metals do not they are presented in such a way that they can be absorbed, distributed and used efficiently.
Os sais dos nutrientes minerais dos ácidos orgânicos ou minerais que são utilizados para combater as síndromes de carência em humanos, animais ou vegetais, apresentam limitações em sua utilização como o sabor metálico que limita sua aceitação e/ou uma baixa solubilidade em água que limita sua absorção ou biodisponibilidade. A absorção dos elementos essenciais depende, na maior parte dos casos, da solubilidade que apresentam os sais que são usados. Assim, como regra geral, quanto maior a solubilidade, maior a absorção.Salts of mineral nutrients from organic or mineral acids that are used to combat deficiency syndromes in humans, animals or plants, have limitations in their use as the metallic taste that limits their acceptance and / or low water solubility that limits their use. absorption or bioavailability. The absorption of the essential elements depends in most cases on the solubility of the salts used. Thus, as a general rule, the higher the solubility, the greater the absorption.
Outro fator interessante é o comportamento biológico do elemento uma vez absorvido. Isto significa que o elemento deve seguir as mesmas vias metabólicas que as conhecidas para os sais considerados de referência.Another interesting factor is the biological behavior of the element once absorbed. This means that the element must follow the same metabolic pathways as those known for reference salts.
Os produtos formados entre os sais de ácidos orgânicos ou minerais, que são produzidos com aminoácidos e/ou sais de amônio geram um produto de sabor mais agradável e com uma solubilidade aumentada.Products formed between salts of organic or mineral acids, which are produced with amino acids and / or ammonium salts, generate a more palatable product with increased solubility.
Foram desenvolvidos no passado diferentes compostos complexos de metais essenciais e aminoácidos com relação 1:1 com o objeto de aumentar a biodisponibilidade de referidos metais quando de sua ingestão (ver patentes 3 941 818, 3 925 433, 3 950 372, 4 021 569, e 4 067 994). Nas referidas patentes, os complexos formados formam quelatos. Quelato é um nome muito elementar que se refere à formação de anéis que incluem, no núcleo metálico, compostos de coordenação. A formação deste tipo de compostos ocorre quando um ligando com mais de um "dente" se coordena no mesmo núcleo metálico.Different complex compounds of essential metals and amino acids with a 1: 1 ratio have been developed in the past to increase the bioavailability of such metals upon ingestion (see patents 3,941,818, 3,925,433, 3,950 372, 4,021,569, and 4,067,994). In said patents, the complexes formed form chelates. Chelate is a very elementary name that refers to the formation of rings that include coordinating compounds in the metal core. Formation of this type of compound occurs when a ligand with more than one "tooth" coordinates in the same metal nucleus.
Os sais da presente invenção não são compostos quelados como os sistemas anteriormente mencionados, ao contrário, são estabilizados por uma ligação dativa e apresentam solubilidades muito elevadas (soluções com mais de 50% em peso ou 400 gramas por litro de água), o que permite a agregação aos alimentos em forma simples e sem modificar os volumes aquosos dos mesmos.The salts of the present invention are not chelated compounds as the aforementioned systems, on the contrary, they are stabilized by a dative bond and have very high solubilities (solutions of more than 50 wt% or 400 grams per liter of water), which allows aggregation to food simply and without changing the aqueous volumes thereof.
BREVE DESCRIÇÃO DA INVENÇÃOBRIEF DESCRIPTION OF THE INVENTION
Assim, é um objeto da presente invenção a obtenção de produtos de sais minerais de ácidos orgânicos ou inorgânicos associados com um aminoácido e/ou sais de amônio que apresentam uma fórmula ou estrutura geral:Thus, it is an object of the present invention to obtain mineral salt products of organic or inorganic acids associated with an amino acid and / or ammonium salts having a general formula or structure:
{[Ac]"" · Me11+ «- η [aminoácido/sal de amônio]} · χ H2O{[Ac] "" · Me11 + «- η [amino acid / ammonium salt]} · χ H2O
em que «- representa uma ligação covalente dativawhere '- represents a dative covalent bond
e que apresentam melhor sabor e maior solubilidade em água, o que os tornam mais biodisponíveis.and have better taste and greater water solubility, which makes them more bioavailable.
E um outro objeto da presente invenção consiste em prover sais de nutrientes minerais estabilizados com aminoácidos e/ou sal de amônio, sendo o metal "Men+" selecionado dentre o grupo que compreende os seguintes cátions: cálcio, magnésio, zinco, ferro, cobre, manganês, sódio, potássio, níquel ou cobalto.And another object of the present invention is to provide amino acid and / or ammonium salt stabilized mineral nutrient salts, the "Men +" metal being selected from the group comprising the following cations: calcium, magnesium, zinc, iron, copper, manganese, sodium, potassium, nickel or cobalt.
No entanto, é um outro objeto da presente invenção prover sais de nutrientes minerais estabilizados com aminoácidos e/ou sal de amônio, onde o ácido é selecionado dentre o grupo consistindo de: ácido fumárico, ácido málico, ácido clorídrico, ou ácido sulfiírico, puros ou associados .However, it is another object of the present invention to provide amino acid and / or ammonium salt stabilized mineral nutrient salts, where the acid is selected from the group consisting of: pure fumaric acid, malic acid, hydrochloric acid, or sulfuric acid or associates.
Além disso, é um outro objeto da presente invenção prover sais de nutrientes minerais estabilizados com aminoácidos e/ou sal de amônio, onde o aminoácido é selecionado dentre o grupo consistindo de: ácido amino acético (glicina) e/ou Usina, e o sal de amônio é orgânico ou inorgânico.Furthermore, it is another object of the present invention to provide amino acid and / or ammonium salt stabilized mineral nutrient salts, where the amino acid is selected from the group consisting of: amino acetic acid (glycine) and / or Plant, and the salt of ammonium is organic or inorganic.
Além disso, é um outro objeto da presente invenção prover um suprimento alimentício que contém os sais minerais estabilizados por aminoácidos e/ou sal de amônio, que possui a capacidade de melhorar a nutrição e saúde dos seres humanos e animais, ao aumentar eficientemente a absorção, distribuição e utilização de minerais.Furthermore, it is another object of the present invention to provide a food supply containing amino acid and / or ammonium salt stabilized mineral salts, which has the ability to improve the nutrition and health of humans and animals by efficiently increasing absorption. , distribution and use of minerals.
Além disso, é um outro objeto da presente invenção prover sais de nutrientes minerais estabilizados com aminoácidos e/ou o sal de amônio em um veículo apropriado, como águas, águas carbonatadas, xaropes, com sucos de frutas naturais ou sintéticos, líquidos ou em pó, iogurtes, sobremesas lácteas, manteiga, queijos e margarinas.Furthermore, it is another object of the present invention to provide amino acid stabilized mineral nutrient salts and / or the ammonium salt in a suitable vehicle, such as waters, carbonated waters, syrups, natural or synthetic fruit juices, liquid or powdered. , yogurts, dairy desserts, butter, cheese and margarines.
Além disso, é um outro objeto da presente invenção prover sais de nutrientes minerais estabilizados com aminoácidos e/ou o sal de amônio em um veículo ou forma selecionado incluindo um comprimido, drágeas, pó efervescente, pó, tabletes, pastilhas, cápsula rígida ou mole para apresentação de um produto farmacêutico, suplemento dietético ou de uso veterinário.Furthermore, it is another object of the present invention to provide amino acid stabilized mineral nutrient salts and / or ammonium salt in a selected vehicle or form including a tablet, dragees, effervescent powder, powder, tablets, lozenges, hard or soft capsule. for the presentation of a pharmaceutical, dietary supplement or veterinary use.
Além disso, é um outro objeto da presente invenção prover sais de nutrientes minerais estabilizados com aminoácidos e/ou o sal de amônio que podem formar parte de produtos farináceos, como pão, massas, bolachas pequenas, bolinhos recheados, alimentos desidratados ou concentrados como caldos de carne, sopas, sobremesas, gelatinas, cereais laminados, em grãos ou extrudados, barras de cereais, grãos de soja inteiros ou derivados, farinhas em pó ou laminadas, e aveias.Furthermore, it is another object of the present invention to provide amino acid stabilized mineral nutrient salts and / or ammonium salt which may form part of farinaceous products such as bread, pasta, small crackers, stuffed dumplings, dehydrated or concentrated foods such as broth. of meat, soups, desserts, jellies, rolled, grained or extruded cereals, cereal bars, whole or derived soya beans, powdered or rolled flours, and oats.
Além disso, é um outro objeto da presente invenção prover sais de nutrientes minerais estabilizados com aminoácidos e/ou sal de amônio no caso em que, quando o veículo usado é aquoso, a solução resultante pode ser usada como um adubo foliar ou como fertilizante. Além disso, é um outro objeto da presente invenção prover um processo para a síntese dos sais minerais estabilizados com aminoácidos e/ou sal de amônio, caracterizado pelo fato por compreender as seguintes etapas:In addition, it is another object of the present invention to provide amino acid and / or ammonium salt stabilized mineral nutrient salts where, when the carrier used is aqueous, the resulting solution may be used as a foliar fertilizer or as fertilizer. Furthermore, it is another object of the present invention to provide a process for the synthesis of amino acid and / or ammonium salt stabilized mineral salts, characterized in that it comprises the following steps:
a) a partir do sal formado previamente que solubiliza em uma solução aquosa do aminoácido e/ou sal de amônio,(a) from the previously formed salt which solubilizes in an aqueous solution of the amino acid and / or ammonium salt;
b) aquece-se e ajusta-se o pH de modo apropriado,(b) heat and adjust the pH accordingly;
c) obtém-se o produto formado em solução aquosa que, por evaporação da água, pode ser obtido como produto em forma de pó seco. Pode-se usar a solução do produto ou o pó seco.c) the product formed in aqueous solution is obtained which upon evaporation of water can be obtained as a dry powder product. You can use the product solution or dry powder.
Além disso, é um outro objeto da presente invenção prover um processo para a síntese de sais de cobre ou ferro ou manganês estabilizados com aminoácidos e/ou sal de amônio, caracterizado por compreender as seguintes etapas:In addition, it is another object of the present invention to provide a process for the synthesis of amino acid and / or ammonium salt stabilized copper or iron or manganese salts, comprising the following steps:
a) substituição dos sais de cálcio formados pelos íons ferroso ou férrico ou cúprico ou de manganês por incorporação dos sulfatos ferroso ou férrico ou cúprico ou de manganês, respectivamente,(a) replacement of the calcium salts formed by ferrous or ferric or cupric or manganese ions by incorporation of ferrous or ferric or cupric or manganese sulphates respectively;
b) precipitação de sulfato de cálcio formado, mantendo-se em solução o sal ferroso ou férrico ou cúprico ou de manganês do mesmo ânion ou ligado com o aminoácido e/ou sal de amônio,(b) precipitation of calcium sulphate formed by maintaining the ferrous or ferric or cupric or manganese salt of the same anion or bound with the amino acid and / or ammonium salt in solution;
c) filtração para separar o sulfato de cálcio precipitado de modo que o produto formado permanece em solução aquosa,c) filtration to separate precipitated calcium sulfate so that the product formed remains in aqueous solution,
d) evaporação da água até obtenção do produto em forma de pó seco.d) evaporation of water until the product is obtained as a dry powder.
Além disso, é um outro objeto da presente invenção prover um processo para a síntese de sais, caracterizado em que compreende as seguintes etapas:Furthermore, it is another object of the present invention to provide a process for the synthesis of salts, characterized in that it comprises the following steps:
a) solubilização da solução aquosa do aminoácido e/ou sal de amônio na relação estabelecida da fórmula geral, b) aquecimento da solução e ajuste do pH,a) solubilization of the aqueous solution of the amino acid and / or ammonium salt in the established ratio of the general formula; b) heating of the solution and pH adjustment;
c) o produto formado é mantido em solução aquosa e pode ser obtido como um pó seco por evaporação da água,c) the formed product is kept in aqueous solution and can be obtained as a dry powder by evaporation of water,
em que os sais são sulfato cúprico, sulfato de zinco, sulfato de potássio, sulfato de sódio, sulfato de manganês, sulfato ferroso, férrico, cloreto de sódio, cloreto de potássio ou cloreto de cálcio.wherein the salts are cupric sulfate, zinc sulfate, potassium sulfate, sodium sulfate, manganese sulfate, ferrous, ferric sulfate, sodium chloride, potassium chloride or calcium chloride.
BREVE DESCRIÇÃO DOS DESENHOSBRIEF DESCRIPTION OF DRAWINGS
Na figura 1, nota-se a amostra de fumarato de zinco associado com glicina (biofumarato de Zn) e o padrão de glicina.Figure 1 shows the sample of glycine-associated zinc fumarate (Zn biofumarate) and the glycine pattern.
Na figura 2, observa-se a amostra de fumarato de zinco associado com glicina (biofumarato de Zn) e padrão de glicina depois da reação com ninidrina.Figure 2 shows the sample of zinc fumarate associated with glycine (Zn biofumarate) and glycine pattern after reaction with ninhydrin.
DESCRIÇÃO DETALHADA DA INVENÇÃODETAILED DESCRIPTION OF THE INVENTION
Foram desenvolvidos produtos de ânions orgânicos como fumarato, salicato, gluconato, lactato, assim como ânions inorgânicos, como sulfatos ou cloretos, em forma pura ou associada de cátions como cálcio, magnésio, ferro, zinco, cobre, manganês, sódio, potássio, cobalto e níquel, associado com aminoácidos como a glicina (ácido amino acético) e/ou L- lisina e/ou sal de amônio.Organic anion products such as fumarate, salicate, gluconate, lactate as well as inorganic anions such as sulfates or chlorides have been developed in pure or associated form of cations such as calcium, magnesium, iron, zinc, copper, manganese, sodium, potassium, cobalt. and nickel, associated with amino acids such as glycine (amino acetic acid) and / or L-lysine and / or ammonium salt.
Os sais formados apresentam uma notável solubilidade maior em água com sabor aceitável, quando avaliados contra o sal não associado tomado como padrão e com igual concentração do íon metálico que é necessário administrar.The salts formed have a remarkable higher solubility in acceptable flavored water when evaluated against the unassociated salt taken as standard and with the same concentration of metal ion that needs to be administered.
Estas características dos produtos formados tornam os mesmos muito utilizáveis para administração de macro- e micronutrientes minerais em suplementos dietéticos, produtos medicinais e em alimentos ou bebidas convenientemente enriquecidos ou fortificados.These characteristics of the formed products make them very usable for administration of macro- and mineral micronutrients in dietary supplements, medicinal products and in suitably fortified or fortified foods or beverages.
A estrutura química geral dos compostos formados responde ao seguinte esquema:The general chemical structure of the formed compounds responds to the following scheme:
{[Ac]n" · Me11+ <- η [aminoácido e/ou sal de amônio]} · χ H2O{[Ac] n "· Me11 + <- η [amino acid and / or ammonium salt]} · χ H2O
em que:on what:
η tem os valores de 1 a 3, eη has the values from 1 to 3, and
χ tem os valores de O a 10.χ has the values from 0 to 10.
O metal Me11+ pode ser cálcio, magnésio, zinco, ferro, cobre, manganês, sódio, potássio, cobalto ou níquel.Me11 + metal can be calcium, magnesium, zinc, iron, copper, manganese, sodium, potassium, cobalt or nickel.
O ácido pode ser ácido fumárico, ácido láctico, ácido glucônico, ácido málico, ácido clorídrico, ou ácido sulfurico, puros ou associados .The acid may be fumaric acid, lactic acid, gluconic acid, malic acid, hydrochloric acid, or sulfuric acid, pure or associated.
O aminoácido pode ser ácido amino acético (glicina) e/ou lisina.The amino acid may be amino acetic acid (glycine) and / or lysine.
O sal de amônio pode ser orgânico ou inorgânico.Ammonium salt can be organic or inorganic.
Foi demonstrada, através do estudo da estrutura do produto formado, a formação de um produto em que o nitrogênio amínico do aminoácido e/ou sal de amônio está ligado ao metal por uma ligação dativa coordenada (ver figuras 1 e 2).It has been demonstrated through the study of the structure of the formed product the formation of a product in which the amino acid amino acid and / or ammonium salt is bound to the metal by a coordinated dative bond (see figures 1 and 2).
A identificação funcional da ligação dativa coordenada com o nitrogênio amínico do aminoácido foi caracterizada pela reação com ninidrina (ver figuras 1 e 2).Functional identification of the dative bond coordinated with amino acid amine nitrogen was characterized by reaction with ninhydrin (see figures 1 and 2).
Na figura 1, observa-se a amostra de fumarato de zinco associado com glicina (biofumarato de Zn) e o padrão de glicina.Figure 1 shows the sample of glycine-associated zinc fumarate (Zn biofumarate) and the glycine pattern.
Na figura 2, nota-se a mesma amostra quando da reação com ninidrina. A cor violeta do padrão de glicina mostra que a glicina está livre. A cor amarela corresponde à reação do produto reivindicado com a ninidrina, a referida reação demonstra que o grupo carboxílico da glicina se encontra livre, enquanto que o grupo amínico está associado ao metal (neste caso Zn). Se a glicina estivesse em estado livre, a cor teria sido violeta. Se, ao contrário, ambos os grupos funcionais da glicina (amino e carboxílico) estivessem ligados ao metal (como ocorre no caso dos compostos aminoquelados) não teria ocorrido a reação com a ninidrina e seria incolor.Figure 2 shows the same sample when reacting with ninhydrin. The violet color of the glycine pattern shows that glycine is free. The yellow color corresponds to the reaction of the claimed product with ninhydrin, said reaction demonstrates that the glycine carboxylic group is free, while the amino group is associated with the metal (in this case Zn). If the glycine were free, the color would have been violet. If, on the contrary, both glycine functional groups (amino and carboxylic) were bonded to the metal (as in the case of amino-chelated compounds) the reaction with ninhydrin would not have occurred and would be colorless.
O produto tem a característica de não formar um quelato e o sal obtido apresenta melhores características de solubilidade e sabor que o sal sozinho.The product has the characteristic of not forming a chelate and the salt obtained has better solubility and taste characteristics than the salt alone.
O objeto da presente invenção é a obtenção de produtos de sais minerais de ácidos orgânicos ou inorgânicos associados com um aminoácido e/ou sal de amônio que apresentam uma estrutura geral:The object of the present invention is to obtain mineral salt products of organic or inorganic acids associated with an amino acid and / or ammonium salt having a general structure:
{[Ac]"' · Me11+ η [aminoácido e/ou sal de amônio]} · χ H2O que apresentam melhor sabor e maior solubilidade em água, o que os tornam mais biodisponíveis.{[Ac] "'· Me11 + η [amino acid and / or ammonium salt]} · χ H2O that have a better flavor and greater water solubility, making them more bioavailable.
Pode-se compreender a formação dos mesmos:One can understand their formation:
a) A partir do sal formado previamente que solubiliza em uma solução aquosa do aminoácido e/ou sal de amônio, aquece-se e ajusta-se o pH em forma apropriada. Obtém-se o produto formado em solução aquosa, que, por evaporação da água, pode-se obter o produto em forma de pó seco. Pode- se usar a solução do produto ou o pó seco.(a) From the previously formed salt which solubilizes in an aqueous solution of the amino acid and / or ammonium salt, the pH is warmed and adjusted accordingly. The product formed in aqueous solution is obtained, which upon evaporation of water can give the product as a dry powder. The product solution or dry powder may be used.
b) Os sais de cálcio formados podem ser substituídos por íons ferroso ou férrico ou cúprico ou manganês por incorporação dos sulfatos ferroso, férrico, cúprico ou de manganês, respectivamente. O sulfato de cálcio formado precipita, mantendo em solução o sal ferroso, férrico, cúprico ou de manganês do mesmo ânion e ligado com o aminoácido e/ou o sal de amônio. Filtra-se para separar o sulfato de cálcio precipitado e o produto formado permanece em solução aquosa, a qual pode, por evaporação da água, ser obtida em forma de pó seco.(b) The formed calcium salts may be replaced by ferrous or ferric or cupric or manganese ions by incorporation of ferrous, ferric, cupric or manganese sulfates respectively. Calcium sulphate formed precipitates by keeping the ferrous, ferric, cupric or manganese salt of the same anion in solution and bound with the amino acid and / or ammonium salt. The precipitated calcium sulphate is filtered to separate and the product formed remains in aqueous solution, which may, by evaporation of water, be obtained as a dry powder.
c) Os sais, como sulfato cúprico, sulfato de zinco, sulfato de potássio, sulfato de sódio, sulfato de manganês, sulfato ferroso ou férrico, podem ser formados também solubilizando os mesmos na solução aquosa do aminoácido na relação estabelecida da fórmula geral, aquecendo-se a solução e ajustando-se o pH. O produto formado permanece em solução aquosa e pode ser obtido como um pó seco por evaporação da água.c) Salts such as cupric sulphate, zinc sulphate, potassium sulphate, sodium sulphate, manganese sulphate, ferrous or ferric sulphate may also be formed by solubilizing them in the aqueous solution of the amino acid in the established ratio of the general formula by heating. the solution and adjusting the pH. The product formed remains in aqueous solution and can be obtained as a dry powder by evaporation of water.
d) Os sais, como cloreto de sódio, cloreto de potássio, cloreto de magnésio, ou cloreto de cálcio, podem ser formados também solubilizando os mesmos na solução aquosa do aminoácido na relação estabelecida da fórmula geral, aquecendo-se a solução e ajustando o pH. O produto formado permanece em solução aquosa e pode ser obtido como pó seco por evaporação da água.d) Salts, such as sodium chloride, potassium chloride, magnesium chloride, or calcium chloride, may also be formed by solubilizing them in the aqueous amino acid solution in the established ratio of the general formula, heating the solution and adjusting the solution. pH. The product formed remains in aqueous solution and can be obtained as a dry powder by evaporation of water.
DADOS COMPARATIVOSDE SOLUBILIDADECOMPARATIVE SOLUBILITY DATA
1. Fumarato ferroso (Ref. 4094 Index Merck XII, Ed. Pág. 686) PM 169,90, teor de Fe++ 32,87%, pa Fe 55,847.1. Ferrous Fumarate (Ref. 4094 Index Merck XII, Ed. Page 686) PM 169.90, Fe ++ 32.87%, for Fe 55.847.
Solubilidade em água a 25°C: 1,4 gramas por litro de água. Permite solubilizar 0,460 g Fe++ (ferroso) por litro de água. Fumarato ferroso estabilizado com 2 mols de glicina (ácido amino acético):Solubility in water at 25 ° C: 1,4 grams per liter of water. It allows to solubilize 0.460 g Fe ++ (ferrous) per liter of water. Ferrous fumarate stabilized with 2 moles of glycine (amino acetic acid):
TeorContent
Fumarato ferroso 169,90 g (53,09%)Ferrous Fumarate 169.90 g (53.09%)
Glicina (2 χ 75,07) 150,14 g (46,91%)Glycine (2 χ 75.07) 150.14 g (46.91%)
Produto 320,04 g (17,45% de Fe).Product 320.04 g (17.45% Fe).
Solubilidade em água a 25°C, como fumarato ferroso estabilizado com 2 mols de glicina: 54,6 g por litro.Solubility in water at 25 ° C as stabilized ferrous fumarate with 2 moles of glycine: 54,6 g per liter.
Como fumarato ferroso (53,9%): 29,0 g/litro. Permite solubilizar 9,53 g Fe++ (ferroso) por litro de água destilada. Aumento da solubilidade por litro: 20,7 vezes (resultado: 9,53 g de Fé / 0,460 g de Fe).As ferrous fumarate (53.9%): 29.0 g / liter. It allows to solubilize 9.53 g Fe ++ (ferrous) per liter of distilled water. Increased solubility per liter: 20.7 times (result: 9.53 g Faith / 0.460 g Fe).
Os dados apresentados mostram, de modo evidente, o aumento da solubilidade em água de um sal como o fumarato ferroso, que se usa como fonte de micronutriente mineral ferro em suplementação dietética em alimentos fortificados.The data presented clearly show the increased water solubility of a salt such as ferrous fumarate, which is used as a source of iron mineral micronutrient in dietary supplementation in fortified foods.
2. Fumarato de cálcio 3H20 Ref. Fabricante Bartek Inc. Canadá) PM 208,18, teor de cálcio 19,25% (pa Ca 40,08). Solubilidade em água a 25°C, C: 1,22 g por litro: permite solubilizar 0,234 g Ca+V litro de água. Fumarato de cálcio 3H2O estabilizado com 2 mols de glicina (ácido amino acético). Fumarato de cálcio 3 H2O: 208,18 58,09% 2. Glicina: 2 χ 75,07 150,14 41,91% 358,32 11,18% como cálcio. Solubilidade em água como fumarato de cálcio estabilizado com 2 mols de glicina: 50,0 g / litro. Como fumarato de cálcio: 29,045 g/litro. Como cálcio (19,25%): 5,591 g cálcio/litro. Aumento da solubilidade : 23,9 vezes (resultante de: 5,591/0,234 g) como cálcio.2. Calcium fumarate 3H20 Ref. Manufacturer Bartek Inc. Canada) PM 208.18, calcium content 19.25% (to Ca 40.08). Solubility in water at 25 ° C, C: 1,22 g per liter: allows to solubilize 0,234 g Ca + V liter of water. Calcium fumarate 3H2O stabilized with 2 mol glycine (amino acetic acid). Calcium fumarate 3 H2O: 208.18 58.09% 2. Glycine: 2 χ 75.07 150.14 41.91% 358.32 11.18% as calcium. Solubility in water as stabilized calcium fumarate with 2 mol glycine: 50,0 g / liter. As calcium fumarate: 29.045 g / liter. As calcium (19.25%): 5.591 g calcium / liter. Increased solubility: 23.9 fold (resulting from: 5.591 / 0.234 g) as calcium.
EXEMPLOS DE REALIZAÇÃOEXAMPLES
Os seguintes exemplos específicos que são apresentados aqui servem para ilustrar a natureza da presente invenção. Estes exemplos são incluídos apenas com fins ilustrativos e não devem ser interpretados como limitações da invenção que aqui é reivindicada.The following specific examples set forth herein serve to illustrate the nature of the present invention. These examples are included for illustrative purposes only and should not be construed as limitations on the invention claimed herein.
Exemplo 1Example 1
Preparação do sal de cálcio como fumarato de cálcio com ácido amino acético (glicina) solução a 5,0%.Preparation of calcium salt as calcium fumarate with amino acetic acid (glycine) 5.0% solution.
1. Em um frasco de precipitação de 2000 cm3, adiciona-se:1. In a 2000 cm3 precipitation bottle, add:
Agua purificada: 1800 g. Pesar o hidróxido de cálcio (mínimo 95%): 24,84 g (corrigir a pureza e umidade). Dispersar em forma homogênea.Purified water: 1800 g. Weigh calcium hydroxide (minimum 95%): 24.84 g (correct purity and humidity). Disperse homogeneously.
2. Pesar o ácido amino acético (98,5% mínimo): 47,92 g e adicionar. Aquecer em banho-maria com agitação.2. Weigh amino acetic acid (98.5% minimum): 47.92 g and add. Heat in a water bath with stirring.
3. Pesar ácido fumárico (9,0% mínimo): 37,05 g, e adicionar. Continuar com o aquecimento em banho-maria, com agitação, de modo a manter a solução entre 60 e 85°C, durante pelo menos 30 minutos.3. Weigh fumaric acid (9.0% minimum): 37.05 g, and add. Continue heating in a water bath with stirring to keep the solution at 60 to 85 ° C for at least 30 minutes.
4. Retirar uma amostra e ajustar o pH da solução a 5% p/p a 6,5 (6,2 a 6,8) usando hidróxido de cálcio ou ácido fumárico, conforme necessário. 5. Uma vez ajustado o pH, avalia-se o cálcio, devendo dar, pelo menos, 0,56 g% de cálcio.4. Take a sample and adjust the pH of the 5% w / w solution to 6.5 (6.2 to 6.8) using calcium hydroxide or fumaric acid as needed. 5. Once the pH has been adjusted, calcium shall be assessed and shall give at least 0,56 g% calcium.
6. A solução obtida é filtrada em papel e preferivelmente com um produto para auxiliar a filtração, obtendo-se uma solução cristalina.6. The obtained solution is filtered on paper and preferably with a filter aid product to give a crystalline solution.
7. A solução obtida pode ser secada ao ar quente, até secura. O pó pode conter no máximo 15% como água de cristalização.7. The solution obtained may be dried in hot air to dryness. The powder may contain a maximum of 15% as crystallization water.
8. Obtém-se aproximadamente 100 a 112 g de produto seco, conforme a água de cristalização.8. Approximately 100 to 112 g of dry product is obtained according to the crystallization water.
9. Na forma industrial, prepara-se a solução em reatores apropriados e a solução é secada por sistema de pulverização.9. In industrial form, the solution is prepared in appropriate reactors and the solution is spray dried.
Exemplo 2Example 2
Preparação de um sal ferroso, como fumarato ferroso com ácido amino acético (glicina), solução a 10%:Preparation of a ferrous salt, such as ferrous fumarate with amino acetic acid (glycine), 10% solution:
oThe
1. Em um frasco de precipitação de 2000 cm , adiciona-se:1. In a 2000 cm drop bottle, add:
Água purificada: 900 ml ou grama. Pesar o hidróxido de cálcioPurified water: 900 ml or gram. Weigh Calcium Hydroxide
(mínimo 95%): 24,84 g (corrigir a pureza e umidade). Dispersar em forma homogênea com agitação.(minimum 95%): 24.84 g (correct purity and humidity). Disperse homogeneously with agitation.
2. Pesar o ácido amino acético (98,5% mínimo): 47,92 g e adicionar. Aquecer em banho-maria com agitação.2. Weigh amino acetic acid (98.5% minimum): 47.92 g and add. Heat in a water bath with stirring.
3. Pesar ácido fumárico (99,0% mínimo). 37,05 g, e adicionar. Continuar com o aquecimento em banho-maria, com agitação, de modo a manter a solução entre 60 e 85°C, durante pelo menos 30 minutos.3. Weigh fumaric acid (99.0% minimum). 37.05 g, and add. Continue heating in a water bath with stirring to keep the solution at 60 to 85 ° C for at least 30 minutes.
4. Retirar uma amostra e ajustar o pH da solução a 5% p/p a 4,5.4. Take a sample and adjust the pH of the 5% w / w solution to 4.5.
5. Uma vez ajustado o pH, adiciona-se: sulfato ferroso 7H20 (mínimo 19,8% Fe+*): 88,74 g. Interrompe-se o aquecimento, continuando a agitação por pelo menos 30 minutos.5. Once the pH is adjusted, add: 7H20 ferrous sulfate (minimum 19.8% Fe + *): 88.74 g. Heating is stopped and stirring is continued for at least 30 minutes.
6. Deixa-se sedimentar, filtra-se o sobrenadante com ajuda de filtração, obtém-se uma solução cristalina esverdeada escura. A solução contém em torno de 1,75% como ferro e 10% (9,5 como 10,5%) como produto em solução.6. Allow to settle, filter supernatant with filtration, give a dark green crystalline solution. The solution contains around 1.75% as iron and 10% (9.5 as 10.5%) as product in solution.
7. A solução obtida pode ser secada por ar quente até secura. A perda por dessecação a 105-108°C deve ser, no máximo, 10%.7. The obtained solution may be dried by hot air to dryness. The desiccation loss at 105-108 ° C should be a maximum of 10%.
8. Obtém-se de 100 a 115 g do produto seco, conforme a água de cristalização.8. 100 to 115 g of the dried product is obtained according to the crystallization water.
9. Em forma industrial, prepara-se a solução em reatores apropriados e pode-se secar por sistema de pulverização.9. In industrial form, the solution is prepared in suitable reactors and may be spray dried.
Claims (16)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP050104763A AR055285A1 (en) | 2005-11-11 | 2005-11-11 | MINERAL SALTS OF MINERALS STABILIZED WITH AMINO ACIDS PRODUCTS AND FOOD SUPPLEMENT THAT UNDERSTAND AND OBTAINING PROCEDURES |
AR20050104763 | 2005-11-11 | ||
PCT/IB2006/003840 WO2007069072A2 (en) | 2005-11-11 | 2006-10-13 | Salts of mineral nutrients stabilized with amino acids and/or ammonium salts, products and food supplements that contain them and methods for obtaining same |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0618638A2 true BRPI0618638A2 (en) | 2011-10-04 |
Family
ID=38163291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0618638-6A BRPI0618638A2 (en) | 2005-11-11 | 2006-10-13 | mineral nutrient salts stabilized with amino acids and / or ammonium salt, product for the treatment of deficiency deficiencies, food supplement, product to be used as fertilizer or foliar fertilizer, and process for the synthesis of mineral salts, and copper or iron or manganese |
Country Status (18)
Country | Link |
---|---|
US (1) | US8523975B2 (en) |
EP (1) | EP1949799A2 (en) |
JP (1) | JP5958849B2 (en) |
KR (1) | KR101346993B1 (en) |
CN (1) | CN101304670A (en) |
AR (1) | AR055285A1 (en) |
AU (1) | AU2006325034A1 (en) |
BR (1) | BRPI0618638A2 (en) |
CA (1) | CA2628162C (en) |
CR (1) | CR10063A (en) |
EG (1) | EG26921A (en) |
IL (1) | IL191256A (en) |
PE (1) | PE20070801A1 (en) |
RU (1) | RU2411877C2 (en) |
UA (1) | UA95785C2 (en) |
UY (1) | UY29911A1 (en) |
WO (1) | WO2007069072A2 (en) |
ZA (1) | ZA200804013B (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY179613A (en) * | 2009-10-30 | 2020-11-11 | Akzo Nobel Chemicals Int Bv | Use of a metal supplement in animal feed |
UA111815C2 (en) | 2009-12-22 | 2016-06-24 | Ралько Ньютрішн, Інк. | ORGANIC CHELATED MINERAL COMPOSITIONS AND METHODS OF THEIR PREPARATION |
WO2012020279A1 (en) | 2010-08-13 | 2012-02-16 | Compagnie Gervais Danone | Product for the upper gastric sphere |
RU2445956C1 (en) * | 2010-10-13 | 2012-03-27 | Федеральное государственное бюджетное учреждение "Российский научный центр "Восстановительная травматология и ортопедия" имени академика Г.А. Илизарова" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "РНЦ "ВТО" им. акад. Г.А. Илизарова" Минздравсоцразвития России) | Method for preparing chelate amino acyl calcium complex |
CN104220385A (en) * | 2012-02-02 | 2014-12-17 | A.O.史密斯公司 | Systems, compositions and methods for providing safe and healthy water and water-based products |
EP2986150A4 (en) * | 2013-04-10 | 2017-01-18 | Smart Salt Inc | Food salt product |
BR112016024191A2 (en) | 2014-04-17 | 2018-09-18 | Ralco Nutrition Inc | agricultural compositions and applications using mineral compounds |
CN104431364B (en) * | 2014-12-10 | 2018-10-23 | 青岛大学 | Application of the natural organic acids root laminine chelate in feed |
MX2015014522A (en) | 2015-10-15 | 2017-04-14 | Centro De Investig Y Asistencia En Tecnologia Y Diseño Del Estado De Jalisco A C | Stabilized soluble calcium in a cationic-anionic polymer and fructans. |
US10766828B2 (en) | 2017-06-01 | 2020-09-08 | Compass Minerals América do Sul Indústria e Comércio S.A. | Liquid fertilizer compositions comprising nickel, cobalt, and molybdenum, and methods of forming and using the same |
US11666071B2 (en) * | 2017-10-25 | 2023-06-06 | Guangzhou Insighter Biotechnology Co., Ltd. | Compound salt of N,N-dimethylglycine and an organic acid and composition and use thereof |
CN107573253B (en) | 2017-10-25 | 2020-03-27 | 广州英赛特生物技术有限公司 | N, N-dimethyl glycine organic acid conjugate acid salt, composition and application thereof |
CN109007752A (en) * | 2018-06-20 | 2018-12-18 | 陈玉海 | A kind of amino acid, vitamine complex peptides salt |
CN111366547A (en) * | 2018-12-26 | 2020-07-03 | 贵州中烟工业有限责任公司 | Detection method for determining α -amino nitrogen in tobacco or tobacco products by using continuous flow method |
CN110074379B (en) * | 2019-04-29 | 2022-01-21 | 雪天盐业集团股份有限公司 | Zinc-rich salt and preparation method thereof |
WO2023177867A1 (en) * | 2022-03-17 | 2023-09-21 | Oconnor Eugene Peter | Glycine-based nutritional food product and beverage compositions and methods of administering and manufacturing same |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES400520A1 (en) * | 1972-02-22 | 1973-01-16 | Debeer Sa | Procedure for obtaining chelates from iron, correctors of ferrous chlorosis in vegetables. (Machine-translation by Google Translate, not legally binding) |
GB1394757A (en) * | 1973-01-02 | 1975-05-21 | Ucb Sa | Lysino-calcium chloride |
US5061815A (en) * | 1988-07-06 | 1991-10-29 | Zinpro Corporation | Metal lysine complexes and method for producing metal lysine complexes |
US4900561A (en) * | 1989-01-03 | 1990-02-13 | Zinpro Corporation | Copper complexes of alpha-amino acids that contain terminal amino groups, and their use as nutritional supplements |
US4948594A (en) * | 1989-01-03 | 1990-08-14 | Zinpro Corporation | Copper complexes of alpha-amino acids that contain terminal amino groups, and their use as nutritional supplements |
US5885610A (en) | 1997-03-04 | 1999-03-23 | Zinpro Corporation | By-pass rumen product |
US6197815B1 (en) * | 1998-03-18 | 2001-03-06 | J.H. Biotech, Inc. | Amino acid chelates to reduce still births and increase birth weight in non-human animals |
US6071545A (en) * | 1999-02-03 | 2000-06-06 | Vyrex Corporation | Metallic oligopeptide complexes |
US6207204B1 (en) * | 1999-06-18 | 2001-03-27 | Albion International, Inc. | Cereal grain kernels fortified with amino acid chelates and method of making |
US6166071A (en) * | 2000-03-13 | 2000-12-26 | Albion International, Inc. | Zinc amino acid chelates having ligands comprised of glycine and a sulfur-containing amino acids |
US20030049284A1 (en) * | 2001-09-05 | 2003-03-13 | Boccio Jose Ruben | Method of increasing the solubility of alphahydrocarboxilic salts, and products obtained by the method |
CN100549015C (en) * | 2002-12-05 | 2009-10-14 | Md白奥阿尔法有限公司 | The preparation method of amino-acid chelate |
US7022351B2 (en) | 2003-01-14 | 2006-04-04 | Zinpro Corporation | Composition for supplementing animals with solutions of essential metal amino acid complexes |
US6911550B2 (en) * | 2003-02-21 | 2005-06-28 | Zinpro Corporation | Derivatives of seleno-amino acids with improved bioavailability and method for their preparation |
-
2005
- 2005-11-11 AR ARP050104763A patent/AR055285A1/en active IP Right Grant
-
2006
- 2006-10-13 UA UAA200807148A patent/UA95785C2/en unknown
- 2006-10-13 KR KR1020087014050A patent/KR101346993B1/en not_active IP Right Cessation
- 2006-10-13 EP EP06848573A patent/EP1949799A2/en not_active Ceased
- 2006-10-13 CN CNA2006800420707A patent/CN101304670A/en active Pending
- 2006-10-13 CA CA2628162A patent/CA2628162C/en not_active Expired - Fee Related
- 2006-10-13 WO PCT/IB2006/003840 patent/WO2007069072A2/en active Application Filing
- 2006-10-13 JP JP2008539537A patent/JP5958849B2/en not_active Expired - Fee Related
- 2006-10-13 RU RU2008120123/13A patent/RU2411877C2/en active
- 2006-10-13 AU AU2006325034A patent/AU2006325034A1/en not_active Abandoned
- 2006-10-13 BR BRPI0618638-6A patent/BRPI0618638A2/en not_active Application Discontinuation
- 2006-10-13 US US12/093,118 patent/US8523975B2/en active Active
- 2006-11-07 PE PE2006001367A patent/PE20070801A1/en not_active Application Discontinuation
- 2006-11-09 UY UY29911A patent/UY29911A1/en not_active Application Discontinuation
-
2008
- 2008-05-05 IL IL191256A patent/IL191256A/en not_active IP Right Cessation
- 2008-05-09 ZA ZA200804013A patent/ZA200804013B/en unknown
- 2008-05-11 EG EG2008050778A patent/EG26921A/en active
- 2008-06-10 CR CR10063A patent/CR10063A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EG26921A (en) | 2014-12-23 |
RU2008120123A (en) | 2009-12-20 |
IL191256A0 (en) | 2009-02-11 |
ZA200804013B (en) | 2009-01-28 |
CA2628162A1 (en) | 2007-06-21 |
CA2628162C (en) | 2014-12-30 |
CN101304670A (en) | 2008-11-12 |
AU2006325034A1 (en) | 2007-06-21 |
KR101346993B1 (en) | 2014-01-02 |
CR10063A (en) | 2009-09-23 |
RU2411877C2 (en) | 2011-02-20 |
IL191256A (en) | 2015-08-31 |
US20080314107A1 (en) | 2008-12-25 |
UA95785C2 (en) | 2011-09-12 |
KR20080069240A (en) | 2008-07-25 |
JP2009515868A (en) | 2009-04-16 |
WO2007069072A2 (en) | 2007-06-21 |
WO2007069072A3 (en) | 2007-11-08 |
AR055285A1 (en) | 2007-08-15 |
JP5958849B2 (en) | 2016-08-02 |
EP1949799A2 (en) | 2008-07-30 |
UY29911A1 (en) | 2007-06-29 |
US8523975B2 (en) | 2013-09-03 |
PE20070801A1 (en) | 2007-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0618638A2 (en) | mineral nutrient salts stabilized with amino acids and / or ammonium salt, product for the treatment of deficiency deficiencies, food supplement, product to be used as fertilizer or foliar fertilizer, and process for the synthesis of mineral salts, and copper or iron or manganese | |
ES2543558T3 (en) | Mixed complexes of metal salts of amino acids | |
AU774654B2 (en) | Bioavailable chelates of creatine and essential metals | |
ES2318199T3 (en) | METAL COMPLEXES OF ALFA-AMINODICARBOXILIC ACIDS. | |
US20210122705A1 (en) | Iron amino acid compounds, method for preparing iron amino acid compounds, compositions containing iron amino acid compounds, and uses thereof | |
JP2009515868A5 (en) | Inorganic nutrient salts stabilized by amino acids, dietary supplements containing inorganic nutrient salts, and solutions containing inorganic nutrient salts used as fertilizers | |
CN101209975B (en) | Levulorotation carnitine calcium fumarate and its preparing method and use | |
BR102015029710A2 (en) | chelated minerals with soy amino acids | |
MX2008006077A (en) | Salts of mineral nutrients stabilized with amino acids and/or ammonium salts, products and food supplements that contain them and methods for obtaining same | |
US20030049284A1 (en) | Method of increasing the solubility of alphahydrocarboxilic salts, and products obtained by the method | |
CN1552247A (en) | Nourishing gourmet powder | |
JP2023147616A (en) | Mineral-bound protein and method for producing the same | |
BRPI1104374A2 (en) | CHEMICAL COMPOUNDS OF AMINO ACIDS AND FUNCTIONAL ORGANIC ACIDS FOR HUMAN, ANIMAL AND VEGETABLE NUTRITION, PRODUCTION PROCESS, COMPOSITIONS CONTAINING THEM AND METHOD FOR TREATMENT | |
BRPI1002480A2 (en) | cell wall containing mineral complexes, preparation processes, compositions containing them and use of these mineral complexes | |
WO2014065890A1 (en) | Fast dissolving solid calcium mineral supplement compositions and process of making | |
BR102013016963A2 (en) | Lysine Compound, Use of a Lysine Compound, Animal Diet Facilitation Process, Process for Adding Lysine to Feed, Animal Feed, Veterinary Food and Pharmaceutical Composition, and Method for Animal Treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] |
Free format text: SOLICITA-SE A REGULARIZACAO DAS PROCURACOES, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA. |
|
B06H | Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette] |
Free format text: ANULADA A EXIGENCIA POR MOTIVO DE A MESMA TER SIDO PUBLICADA INDEVIDAMENTE. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM OS ARTIGOS 8O, 11, 13 E 25 DA LPI. |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Ipc: A23K 20/20 (2016.01), A23D 7/005 (2006.01), A23K 2 |